USE OF LINAGLIPTIN IN CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY

摘要

PROBLEM TO BE SOLVED: To provide novel pharmaceutical compositions that allow treatment of diabetes simultaneously with prevention or treatment of, e.g., (renal) microvascular complications, macrovascular (CV) complications, cognitive impairment, depression, emotional disorder and anxiety disorder in diabetic patients at high vascular risk.;SOLUTION: A pharmaceutical composition for treating a diabetic patient with or at risk for a cardiovascular and/or renal microvascular disease contains linagliptin, or a pharmaceutically acceptable salt thereof, optionally in combination with one or more other active agents.;SELECTED DRAWING: None;COPYRIGHT: (C)2019,JPO&INPIT